Latham & Watkins represented Revolution Medicines, while Davis Polk advised the underwriters in the offering.Revolution Medicines, Inc. (Nasdaq: RVMD), has announced the pricing of its underwritten public…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Laura Testa
…
This content is for Standard 1 Year members only. LoginJoin Now